Clinical Trial Update: Individually Adapted Therapy Duration for the Treatment of Chronic Hepatitis C Genotype 1 Infection [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating individually adapted therapy durations for chronic hepatitis C genotype 1 infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: FGK Clinical Research GmbH | Conditions: Hepatitis C, Chronic | Phase 4 | Status: COMPLETED